A procedure to attenuate live influenza virus of type A and type B was developed using adaptation of the virus to grow at 25 degrees C (cold adaptation; ca). Through a series of stepwise passages, two stable mutants were obtained and designated as 'Master' strains, one for type A influenza virus (A/
β¦ LIBER β¦
An Attenuated Live Virus Vaccine for Myxomatosis
β Scribed by MCKERCHER, D. G.; SAITO, J. K.
- Book ID
- 109635917
- Publisher
- Nature Publishing Group
- Year
- 1964
- Tongue
- English
- Weight
- 267 KB
- Volume
- 202
- Category
- Article
- ISSN
- 0028-0836
- DOI
- 10.1038/202933a0
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The development of live attenuated cold-
β
Hunein F. Maassab; Martin L. Bryant
π
Article
π
1999
π
John Wiley and Sons
π
English
β 103 KB
π 1 views
An Attenuated Strain of the Myxomatosis
β
MYKYTOWYCZ, R.
π
Article
π
1953
π
Nature Publishing Group
π
English
β 229 KB
Rationalizing the development of live at
β
Jones, Jeremy O; Andino, Raul; Lauring, Adam S
π
Article
π
2010
π
Nature Publishing Group
π
English
β 484 KB
Further observations on immunization wit
β
Yoshiomi Okuno
π
Article
π
1965
π
Springer Vienna
π
English
β 262 KB
Live attenuated vaccines for human use
β
Stanley J. Cryz Jr.
π
Article
π
1992
π
Elsevier Science
π
English
β 557 KB
Live attenuated vaccines have been successfully used for the prevention of a number of viral and bacterial diseases. Several vaccine strains have been utilized recently as expression vectors for cloned heterologous antigens. Through the use of recombinant DNA technology, candidate vaccine strains an
Isolation of an attenuated myxoma virus
β
J. BΓ‘rcena; A. PagΓ¨s-MantΓ©; R. March; M. Morales; M. A. RamΓrez; J. M. SΓ‘nchez-V
π
Article
π
2000
π
Springer Vienna
π
English
β 159 KB